The relationship between TG2 and p53 suggests a possible mechanism for glucose tolerance abnormalities-associated pancreatic cancer and could have therapeutic potential for cancer treatment and diagnosis. The gene discussed is TP53; the disease is familial pancreatic carcinoma.